US2014301998A1PendingUtilityA1
Preparation containing diol
Est. expiryFeb 8, 2022(expired)· nominal 20-yr term from priority
A61P 17/16A61K 2800/59A61K 9/0014A61K 8/345A61K 47/10A61Q 19/007A61Q 19/00
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a cosmetic or dermatological formulation comprising a) at least one polyol in a concentration of from 0.1 to 20% by weight, based on the total weight of the formulation, and b) at least one diol selected from 2-methyl-1,3-propanediol, pentanediol, and hexanediol, in a concentration of from 0.1 to 25% by weight, based on the total weight of the formulation.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A cosmetic or dermatological formulation, wherein the formulation comprises
(a) one or more of glycerol, propylene glycol, and butylene glycol in a total concentration of from 0.1% to 20% by weight, based on a total weight of the formulation, (b) 2-methyl-1,3-propanediol and, optionally, one or both of pentanediol and hexanediol in a total concentration of from 1% to 25% by weight, based on the total weight of the formulation, 2-methyl-1,3-propanediol being present in a concentration of from 1% to 15% by weight, and (c) at least one substance selected from antioxidants, alpha-lipoic acid, phytoene, D-biotin, coenzyme Q10, α-glucosylrutin, carnitine, carnosine, isoflavonoids, creatine, taurine, and β-alanine,
and wherein a ratio of (a) to (b) is from 5:1 to 1:1.
2 . The formulation of claim 1 , wherein the formulation is present as an ointment, a cream, a milk, a lotion or a spray.
3 . The formulation of claim 1 , wherein glycerol, propylene glycol, butylene glycol and 2-methyl-1,3-propanediol are present in a total concentration of at least 7.5% by weight.
4 . The formulation of claim 1 , wherein (a) comprises glycerol.
5 . The formulation of claim 1 , wherein (b) comprises pentanediol.
6 . The formulation of claim 1 , wherein (b) comprises hexanediol.
7 . The formulation of claim 1 , wherein (c) comprises at least one substance selected from alpha-lipoic acid, phytoene, D-biotin, coenzyme Q10, α-glucosylrutin, carnitine, carnosine, isoflavonoids, creatine, taurine, and β-alanine.
8 . The formulation of claim 1 , wherein (b) is present in a total concentration of from 3% to 8% by weight.
9 . The formulation of claim 8 , wherein (a) is present in a total concentration of from 1% to 15% by weight.
10 . The formulation of claim 9 , wherein the ratio of (a) to (b) is from 2:1 to 1:1.
11 . The formulation of claim 1 , wherein (a) comprises at least one of propylene glycol and butylene glycol.
12 . A cosmetic or dermatological formulation, wherein the formulation is present as an ointment, a cream, a milk, a lotion or a spray and comprises
(a) one or both of propylene glycol and butylene glycol and, optionally, glycerol in a total concentration of from 0.1% to 20% by weight, based on a total weight of the formulation, and (b) 2-methyl-1,3-propanediol and, optionally, one or both of pentanediol and hexanediol in a total concentration of from 1 to 25% by weight, based on the total weight of the formulation, 2-methyl-1,3-propanediol being present in a concentration of from 1% to 15% by weight,
and wherein a ratio of (a) to (b) is from 1:3 to 3:1.
13 . The formulation of claim 12 , wherein the formulation is present as an ointment, a cream, a milk, a lotion or a spray.
14 . The formulation of claim 13 , wherein glycerol, propylene glycol, butylene glycol and 2-methyl-1,3-propanediol are present in a total concentration of at least 7.5% by weight.
15 . The formulation of claim 13 , wherein (b) is present in a total concentration of from 3% to 8% by weight.
16 . The formulation of claim 12 , wherein the ratio of (a) to (b) is from 2:1 to 1:1.
17 . A cosmetic or dermatological formulation, wherein the formulation comprises
(a) one or more of glycerol, propylene glycol, and butylene glycol in a total concentration of from 0.1% to 20% by weight, based on a total weight of the formulation, and (b) 2-methyl-1,3-propanediol and one or both of pentanediol and hexanediol in a total concentration of from 1% to 25% by weight, based on the total weight of the formulation, 2-methyl-1,3-propanediol being present in a concentration of from 1% to 15% by weight,
and wherein a ratio of (a) to (b) is from 1:3 to 3:1.
18 . The formulation of claim 17 , wherein the formulation is present as an ointment, a cream, a milk, a lotion or a spray.
19 . The formulation of claim 18 , wherein (b) is present in a total concentration of from 3% to 8% by weight.
20 . The formulation of claim 19 , wherein the ratio of (a) to (b) is from 2:1 to 1:1.Join the waitlist — get patent alerts
Track US2014301998A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.